Trademarks

CURE SARCOMA

Serial number
98796540
Registration number
Not registered
Filed
2024-10-11
Registered
Not registered
Status
Abandoned 2025-09-29 (USPTO status code 602, 2025-10-09; as of the dataset)
Classes
041
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRTYRAP, file of 2026-04-03

Goods and services

Services relating to sarcoma including, but not limited to, Providing a website featuring information and news about sarcoma, sarcoma treatment centers, and sarcoma clinical trials, and which allows for the creation of dedication pages to honor a loved one's legacy, Funding research awards in the field of sarcoma, Providing webinars and conferences about sarcoma, Promoting public awareness of sarcoma by means of public advocacy, Charitable fundraising services for promoting research, education and other activities relating to sarcoma, Providing a sarcoma clinical trial matching service, Providing fundraising activities for persons impacted by sarcoma, Providing support services to persons impacted by sarcoma; online retail store services

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Sarcoma Foundation of America, Inc.Original applicantEntity Code 56Damascus, MDSARCOMA FOUNDATION OF AMERICA, INC. State business registration EXACT high confidence: identical full name and state
SARCOMA FOUNDATION OF AMERICA INC Nonprofit EXACT high confidence: identical full name and state
TRTYRAP, file of 2026-04-03

Assignment history

No recorded assignments on file for this mark.

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.